Charcot foot in diabetes: Farewell to the neurotrophic theory

Hormone and Metabolic Research

Volumn 38, Issue 6, 2006, Pages 361-367

  Chantelau, E ^a   Onvlee, G J ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Heinrich Heine Universität ^*

Author keywords

Amputation; Diabetic foot; Neuroarthropathy; Osteoarthropathy; Osteoporosis; Polyneuropathy

Indexed keywords

AUTONOMIC DENERVATION; BONE DEMINERALIZATION; BONE TURNOVER; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE COURSE; FOOT AMPUTATION; FOOT MALFORMATION; FOOT ULCER; HUMAN; NEUROPATHIC JOINT DISEASE; OSTEOARTHROPATHY; OSTEODYSTROPHY; OSTEOLYSIS; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; TABES DORSALIS;

ARTHROPATHY, NEUROGENIC; BONE AND BONES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FRACTURES, BONE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MODELS, BIOLOGICAL;

EID: 33745876824     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-944525     Document Type: Review

References (66)

1. Onvlee GJ. The Charcot Foot. A critical review and an observational study of a group of 60 patients. Thesis. Medical Faculty, University of Leiden/The Netherlands: 1998
2. Horwitz T. Bone and cartilage debris in the synovial membrane: Its significance in the early diagnosis of neuro-arthropathy. J Bone Joint Surg 1948; 30-A: 579-588
3. Edmonds ME, Watkins PJ. The charcot joint: understanding its natural history leads to new treatment and prevention. Abstract. Diabetic Med 1984; 1: 144 A
4. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999; 38: 34-40
5. Frykberg RG. Charcot foot: an update on pathogenesis and management. In: Boulton AJM, Connor H, Cavanagh PR (eds). The foot in Diabetes. 3rd edn. Chichester: John Wiley&Sons, 2000: 235-260
6. Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc 2002; 94: 210-220
7. Chantelau E. The perils of procrastination: effects of early versus delayed detection and treatment of incipient Charcot fracture. Diabetic Med 2005; 22: 1707-1712
8. Eichenholtz SN. Charcot joints. Springfield, Illinois: Charles C. Thomas, 1966: (quoted by Yu et al. [6], Frykberg [5] and Eckardt et al. [9])
9. Eckardt A, Schöllner C, Decking J, Ritter S, Schadmand-Fischer S, Kraus O, Küstner E. The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy. Arch Orthop Trauma Surg 2004; 124: 145-150
10. Piaggesi A, Marcocci C, Golia F, Di Gregorio S, Baccetti F, Navalesi R. Markers for Charcot's neurogenic osteo-arthropathy in diabetic patients. Abstract. Diabetes 2000; 49 (Suppl. 1): A 32
11. Piaggesi A, Rizzo L, Golia F et al. Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. Diabetes Res Clin Pract 2002; 58: 1-9
12. Gough A, Abrara H, Li F, Purewal TS, Foster AVM, Watkins PJ, Moniz C, Edmonds ME. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabetic Med 1997; 14: 527-531
13. Jude EB, Selby PL, Mawer EB, Burgess J, Boulton AJM. Inflammatory and bone turnover markers in Charcot arthropathy and osteomyelitis of the feet in diabetic patients. Abstract. Diabetologia 2002; 45 (Suppl. 2): A 341-342
14. Meier C, Liu PY, Handelsman DJ, Seibel MJ. Endocrine regulation of bone turnover in men. Clinical Endocrinology 2005; 63: 603-616
15. McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques. Diabetologia 2000; 43: 481-484
16. Eymontt MJ, Alavi A, Dalinka MK, Kyle GC. Bone scintigraphy in diabetic osteoarthropathy. Radiology 1982; 140: 475-477
17. van Schie CHM, Carrington AL, Abouaesha F, Boulton AJM, Jude EB. Neuropathic and vascular profiles in diabetic patients with Charcot neuroarthropathy. Abstract. Diabetes 2002; 51 (Suppl. 2): A 543
18. Stevens MJ, Edmonds ME, Foster AVM, Watkins PJ. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 1992; 35: 148-154
19. Shapiro S, Stansberry KB, Hill MA, Meyer MD, McNitt PM, Bhatt BA, Vinik AI. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diab Compl 1998; 12: 147-153
20. Charcot JM. Sur quelques arthropathies qui paraissent dependre d'une lesion du cerveau ou de la moelle epiniere. Archives de Physiologie normale et pathologique 1868; 1: 161-178
21. Charcot JM, Féré C. Affections osseuses et articulaires du pied chez les tabetiques (Pied tabetique). Archives de Neurologie 1883; 6: 305-319
22. Sanders LJ. The Charcot foot: historical perspective 1827-2003. Diabetes Metab Res Rev 2004; 20 (Suppl. 1): S4-S8
23. Eloesser L. On the nature of neuropathic affections of joints. Ann Surg 1917; 66: 201-207
24. O'Connor BL, Palmoski MJ, Brandt KD. Neurogenic acceleration of degenerative joint lesions. J Bone and Joint Surg 1985; 67-A: 562-572
25. LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes. New Engl J Med 1984; 311: 1615-1619
26. Selby PL. Osteopenia and diabetes. Diabetic Med 1988; 5: 423-428
27. Johnson LC. Comment to Williams et al. Arthritis Rheum 1966; 9: 358-359
28. Brower AC, Allman RM. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 1981; 139: 349-354
29. Watkins PJ, Edmonds ME. Sympathetic nerve failure in diabetes. Diabetologia 1983; 25: 73-77
30. Boulton AJM. The diabetic foot: neuropathic in aetiology? Diabetic Med 1990; 7: 852-858
31. Flynn MD, Edmonds ME, Tooke JE, Watkins PJ. Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia 1988; 31: 652-656
32. Edmonds ME, Clarke MB, Newton S, Barrett J, Watkins PJ. Increased uptake of radiopharmaceutical in diabetic neuropathy. Q J Med 1985; 57: 843-855
33. Mailis A, Meindok H, Papagapiou M, Pham D. Alterations of three-phase bone scan after sympathectomy. Clin J Pain 1994; 10: 146-155
34. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympatheic innervation of osteoblastic and osteoclastic cells. Micros Res Tech 2002; 58: 77-84
35. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol 2000; 192: 4-13
36. Udagawa N. Mechanisms involved in bone resorption. Biogerontology 2002; 3: 79-83
37. Barnas U, Schmidt A, Seidl G, Kaider A, Pietschmann P, Mayer G. A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients with chronic hemodialysis. Am J Kidney Dis 2001; 37: 1247-1252
38. Thompson RC, Havel P, Goetz F. Presumed neurotrophic skeletal disease in diabetic kidney transplant recipients. JAMA 1983; 249: 1317-1319
39. Hadjidakis DJ, Lempert UG, Minne HW, Ziegler R. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia. Horm Metab Res 1993; 25: 77-81
40. Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg (Br) 2004; 86-B: 378-383
41. Jirkovska A, Kasalicky P, Boucek P, Hosova J, Skibova J. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabetic Med 2001; 18: 495-500
42. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJM. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1985; 18: 34-38
43. Hastings MK, Sinacore DR, Fielder FA, Johnson JE. Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Physical Therapy 2005; 85: 250-256
44. Schwartz AV. Diabetes mellitus: does it affect bone? Calcif Tissue Int 2003; 73: 515-519
45. Hadjidakis DJ, Raptis AE, Mylonakis A, Katsavochristos P, Sfakianakis M, Raptis SA. The postmenopause in diabetes: bone quality and quantity. Abstract. Diabetologia 2001; 44 (Suppl. 1): A223
46. Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991; 49: 155-160
47. Petrova NL, Foster AVM, Edmonds ME. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type-1 and Type-2 diabetes. Diabetic Med 2005; 22: 756-761
48. Arun CA, Moulik P, Thomas J, Vora JP, Fraser WG, Purewal TS. Does peripheral neuropathy affect bone density of the lower limbs in patients with type-2 diabetes mellitus? Abstract. Diabetic Med 2001; 18 (Suppl. 2): 72
49. Subramanian V, Thomas A, Skowsky R. Evaluation of serum markers of bone turnover and osteopenic risk factors in Type-2 diabetics with and without peripheral neuropathy. Abstract. Diabetes 1999; 48 (Suppl. 1): A144
50. Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabetic Med 2000; 17: 253-258
51. Anonymous Berliner medicinische Gesellschaft.. Sitzung vom 17. November 1886 (in German). Berliner Klinische Wochenschrift 1886; 23: 851-855
52. Chantelau E, Richter A, Schmidt-Grigoriadis P, Scherbaum WA. The diabetic Charcot foot: MRI discloses bone stress injury as trigger mechanism of neuroarthropathy. Experimental and Clinical Endocrinology and Diabetes 2006; 114: 118-123
53. Petrova N, Donaldson N, Bates M, Foster AVM, Edmonds ME. In Charcot osteoarthropathy early offloading prevents bone mineral density falls not only in the Charcot foot but in the contralateral non-Charcot-foot. Abstract. Diabetic Med 2005; 22 (Suppl. 2): 92
54. Edmonds ME, Petrova N, Elias D. The earliest magnetic resonance imaging sign of mid-foot Charcot osteoarthropathy is oedema of the subchondral (subarticular) bone marrow which needs prompt therapeutic offloading. Abstract. Diabetic Med 2005; 22 (Suppl. 2): 93
55. Pinar H, Akseki D, Kovanlikaya I, Arac S, Bozkurt M. Bone bruises detected by magnetic resonance imaging following lateral ankle sprains. Knee Surg, Sports Traumatol, Arthroscopy 1997; 5: 113-117
56. Luetters CM, Keegan THM, Sidney S, Quesenberry CP, Prill M, Sternfeld B, Kelsey J. Risk factors for foot fracture among individuals aged 45 years and older. Osteoporosis Int 2004; 15: 957-963
57. Boddenberg U. Healing time of foot an ankle fractures in patients with diabetes mellitus: literature review and report on own cases. Zentralbl Chir 2004; 129: 453-459
58. Jones KB, Maiers-Yelden KA, Marsh JL, Zimmermann MB, Estin M, Saltzmann CL. Ankle fractures in patients with diabetes mellitus. J Bone Joint Surg 2005; 87-B: 489-495
59. Chantelau E, Richter A, Ghassem-Zadeh N, Poll LW. "Silent" bone stress injuries in the feet of diabetic patients with polyneuropathy - a report on 12 cases. Arch Orthop Trauma Surg 2006; 126 (in press)
60. Forst T, Pfützner A, Kann P et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabetic Med 1995; 12: 874-879
61. Rix M, Andreassen H, Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type-1 diabetes. Diabetes Care 1999; 22: 827-831
62. Patrick AW, Collier A, Nicoll JJ, Pye DW, Young RJ, Clarke BF. Bone mass in the foot and axial skeleton in diabetic patients with peripheral neuropathy. Abstract. Diabetologia 1990; 33 (Suppl. 1): A168
63. Robertson DD, Mueller MJ, Smith KE, Commean PK, Pilgram T, Johnson JE. Structural changes in the forefoot of individuals with diabetes and a prior plantar ulcer. J Bone J Surg 2002; 84-A: 1395-1404
64. Petrova NL, Edmonds ME. Osteopenia in chronic Charcot osteoarthropathy-differences in Type-1 and Type-2 diabetic patients. Abstract. Diabetologia 2002; 45 (Suppl. 2): A341
65. Cundy TF, Edmonds ME, Watkins PJ. Osteopenia and metatarsal fractures in diabetic neuropathy. Diabetic Med 1985; 2: 461-464
66. Krishnan STM, Quattrini C, Jeriyoska M, Malik R, Rayman G. Role of small fibre neuropathy in wound healing in type-2 diabetes. Abstract. Diabetic Med 2006; 23 (Suppl. 2): 69